Elsevier

Nutrition

Volume 20, Issues 7–8, July–August 2004, Pages 709-715
Nutrition

Review article
Supplementation of l-carnitine in athletes: does it make sense?

https://doi.org/10.1016/j.nut.2004.04.003Get rights and content

Abstract

Studies in athletes have shown that carnitine supplementation may foster exercise performance. As reported in the majority of studies, an increase in maximal oxygen consumption and a lowering of the respiratory quotient indicate that dietary carnitine has the potential to stimulate lipid metabolism. Treatment with l-carnitine also has been shown to induce a significant postexercise decrease in plasma lactate, which is formed and used continuously under fully aerobic conditions. Data from preliminary studies have indicated that l-carnitine supplementation can attenuate the deleterious effects of hypoxic training and speed up recovery from exercise stress. Recent data have indicated that l-carnitine plays a decisive role in the prevention of cellular damage and favorably affects recovery from exercise stress. Uptake of l-carnitine by blood cells may induce at least three mechanisms: 1) stimulation of hematopoiesis, 2) a dose-dependent inhibition of collagen-induced platelet aggregation, and 3) the prevention of programmed cell death in immune cells. As recently shown, carnitine has direct effects in regulation of gene expression (i.e., carnitine-acyltransferases) and may also exert effects via modulating intracellular fatty acid concentration. Thus there is evidence for a beneficial effect of l-carnitine supplementation in training, competition, and recovery from strenuous exercise and in regenerative athletics.

Introduction

Dietary supplements to improve performance are familiar to many athletes. Manufacturers more or less aggressively claim that the substances improve the performance of athletes (i.e., act as ergogenic aids) and/or speed up their recovery from exercise. Most of these claims are purely speculative and based on assumptions about how the dietary supplement influences metabolism. The substance l-carnitine has been particularly popular as a potential ergogenic aid because of its role in the conversion of fat into energy.1, 2 For a scheme, the reader is referred to Figure 1.

l-carnitine was first discovered in muscle extracts by two Russian scientists3 who named the substance for the Latin word carnis (flesh or meat). Its chemical structure was established in 1927, and in 1935 a pioneer article about l-carnitine was published,4 which triggered numerous studies on the physiological functions of the chemical. In 1959 Fritz showed that carnitine increases long-chain fatty oxidation in liver and heart.5 Another name for l-carnitine was vitamin B T (T = tenebrio) because the larva of black beetle Tenebrio molitor (Tenebrionidae, Coleoptera) requires l-carnitine as a growth factor in addition to folic acid and other known B vitamins. Considering the chemical structure, the choline-like metabolite l-carnitine (3-hydroxy-4-N,N,N-trimethylaminobutyrate, L-3-hydroxy-4-N-trimethylaminobutyric acid or γ-trimethylamino-β-hydroxybutyric acid) is a quaternary amine. In phrenic nerve diaphragm preparations, its effect, namely induction of tetanic fade, can be reduced by addition of choline.6

The function that has been investigated most thoroughly scientifically is the carnitine-dependent transport of fatty acids through the inner mitochondrial membrane. Other established functions of l-carnitine are the preservation of membrane integrity, the stabilization of a physiologic coenzyme A (CoA) acetyl-CoA (coASH) ratio in mitochondria, and the reduction of lactate production.7, 8 In vitro investigations have strongly supported the notion that l-carnitine is able to inhibit apoptosis (programmed cell death)9, 10, 11 (Figure 2).

The intracellular homeostasis of carnitine is controlled by different membrane transporters. The organic cation transporters (OCTNs), in particular OCTN2, physiologically the most important, operate on intestinal absorption and renal reabsorption of l-carnitine and play a major role in tissue distribution and variations in transport rates. Inborn or acquired defects on this carnitine transport mechanism lead to primary or secondary carnitine deficiency. The OCTN2 mRNA content of cells is reduced with aging12 and by oxygen radicals.13 OCTN2 is directly inhibited by several agents and substances known to induce systemic carnitine deficiency.

Secondary carnitine deficiency is often seen in patients on regular hemodialysis,14 with metabolic disorders, and in pregnancy.15

l-carnitine, widely available over the counter, is also favored among athletes. Rumors that l-carnitine supplementation helped the Italian national soccer team to win the world championship in 1982 contributed immensely to its popularity. The most important claim relates to the role of carnitine in fat metabolism. l-carnitine is often advertized to improve fat metabolism, reduce fat mass, and increase muscle mass. In other words, the substance is portrayed as a “fat burner.” Therefore, carnitine is often recommended for conditions in which weight loss is indicated. Endurance athletes use carnitine to increase the oxidation of fat during exercise and spare muscle glycogen. This review critically examines whether the claims associated with l-carnitine are justified.

Section snippets

Endogenous synthesis and regulation of carnitine body pools

Carnitine is synthesized in mammals from the essential amino acids lysine and methionine.16, 17 Availability of the intermediate trimethyl lysine limits carnitine biosynthesis, and most of the trimethyl lysine body stores are located in skeletal muscle protein. As a consequence, skeletal muscle protein turnover is considered to be the rate-limiting step in carnitine biosynthesis.18 The last step, the hydroxylation of butyrobetaine to carnitine, is limited to liver, kidney, and brain; other

Carnitine in the human body

Skeletal muscles are the main reservoir of l-carnitine in the body and possess an l-carnitine concentration at least 50 to 200 times higher than in blood plasma, where average concentrations are between 41 (females) and 50 (males) μM/L.20 Considering diet, red meat and dairy products represent the major sources. Even with a diet largely lacking carnitine, healthy humans are able to synthesize enough of it. Therefore, l-carnitine is not regarded as a vitamin, but as a vitamin-like substance.

Role of carnitine in fat metabolism

l-carnitine plays an important role in fat metabolism. In the overnight-fasted state, during the resting state, and during exercise of low to moderate intensity, long-chain fatty acids represent up to 80% of the energy sources. The best described function of l-carnitine is in its role as a cofactor of carnitine, acyltransferases transporting long-chain fatty acids across the mitochondrial inner membrane.21 In the absence of l-carnitine, the inner mitochondrial membrane would be impermeable to

Buffering the mitochondrial coenzyme A pool

In some metabolic conditions, e.g., exercise, ischemia, fasting or acute stress, increased PDH activity and fatty acid supply from activated lipolysis may exceed the rate of acetyl-CoA oxidation, which leads to an accumulation of acetyl-CoA and of short-chain acyl-CoA esters, which are mainly degradation products of branched-chain amino acids. The acetyl-CoA/CoASH ratio is an important regulating factor of the oxidation of pyruvate, α-ketoglutarate, and fatty acids. All of them depend on the

Carnitine as a weight loss agent

The rationale for carnitine supplementation as a weight-loss agent is based on the assumption that regular oral ingestion of the substance increases its intracellular concentration. This would trigger increased fat oxidation and gradual reduction of the body's fat reserves. Several studies have shown that oral carnitine ingestion (up to 6 g/d for 14 d) does not change muscle carnitine concentration in healthy non-obese humans and does not promote weight loss.32, 33 This is not in keeping with

Exercise

Carnitine is critical for normal skeletal muscle bioenergetics for at least three reactions. First, l-carnitine is required for long-chain fatty acid oxidation; second, it assists in removing accumulated acyl groups from the mitochondria; and third, it plays an important role in detoxification. Muscles require optimum performance of these metabolic processes during peak exercise. Theoretically, carnitine availability may be the limiting factor for fatty acid oxidation or the removal of

Immune system

Acute bouts of prolonged, strenuous exercise are often associated with immune suppression and an increased risk of infection.71 Although high-performance athletes cannot be described as clinically immune deficient, there is evidence that several parameters of the immune system are suppressed after prolonged periods of intense physical exercise. These are decreases in neutrophil function, serum and salivary immunoglobulin concentrations, natural killer cell activity, secretory immunoglobulin A

Safety aspects of l-carnitine

It is not easy to make a clear distinction or classification for a substance, which, on one hand, is synthesized endogenously and, on the other, has to be taken with food. l-carnitine belongs to a group of substances that is sold over the counter as a nutritional supplement but is also a prescribed drug. Because the investigations refer to a heterogeneous population of humans, large individual variations have to be taken into account. An LD for carnitine in rats was determined as 8.9 to 9.1

Conclusions and directions for further work

On a theoretical basis, the benefits of carnitine supplementation for skeletal muscle during exercise in athletes have been documented in more than 300 subjects participating in placebo-controlled studies. However, interindividual differences in response to supplementation should be taken into account when carnitine is applied as an ergogenic aid and for weight control. In addition, l-carnitine may attenuate side effects of high-intensity training by reducing the magnitude of exercise-induced

References (93)

  • R. Huertas et al.

    Respiratory chain enzymes in muscle of endurance athleteseffect of l-carnitine

    Biochem Biophys Res Commun

    (1992)
  • E.P. Brass et al.

    Carnitine metabolism during exercise

    Life Sci

    (1994)
  • E.P. Brass

    Supplemental carnitine and exercise

    Am J Clin Nutr

    (2000)
  • S. Moretti et al.

    Effect of l-carnitine on human immunodeficiency virus-1 infection-associated apoptosisa pilot study

    Blood

    (1998)
  • J.G. Pastorino et al.

    Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition

    J Biol Chem

    (1993)
  • L. Di Marzio et al.

    Acetyl-l-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjectscorrelation with its suppressive effect on lymphocyte apoptosis and ceramide generation

    Clin Immunol

    (1999)
  • S. Pugazhenthi et al.

    Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein

    J Biol Chem

    (1999)
  • E.J. Sulkers et al.

    Effects of high carnitine supplementation on substrate utilization in low-birth-weight infants receiving total parenteral nutrition

    Am J Clin Nutr

    (1990)
  • B. Li et al.

    The effect of enteral carnitine administration in humans

    Am J Clin Nutr

    (1992)
  • P. Cerretelli et al.

    l-carnitine supplementation in humans. The effects on physical performance

    Int J Sports Med

    (1990)
  • W.K.R. Gulewitsch

    Zur Kenntnis der Extraktionsstoffe der Muskeln. 2. Mitteilungen über das Carnitin (extracted substances in muscle, report on carnitine)

    Hoppe-Seyler Z Physiol Chem

    (1905)
  • E. Strack et al.

    Über den Gehalt von Cholin, Acetylcholin und Carnitin im Muskel (content of choline acetylcholine and carnitine in muscle)

    Hoppe-Seyler Z Physiol Chem

    (1935)
  • I.B. Fritz

    Action of carnitine on long chain fatty acid oxidation by liver

    Am J Physiol

    (1959)
  • G. Lopes et al.

    l- and dl-carnitine induce tetanic fade in rat neuromuscular preparation

    Braz J Med Biol Res

    (2003)
  • N. Siliprandi et al.

    Clinical use of carnitine. Past, present and future

    Adv Exp Med Biol

    (1990)
  • G. Brevetti et al.

    Increases in walking distance in patients with peripheral vascular disease treated with l-carnitinea double-blind, cross-over study

    Circulation

    (1988)
  • G. Vescovo et al.

    l-carnitinea potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure

    Am J Physiol Cell Physiol

    (2002)
  • L. Di Marzio et al.

    Influence of l-carnitine on CD95 cross-lining-induced apoptosis and ceramide generation in human cell linescorrelation with its effects on purified acidic and neutral sphingomyelinases in vitro

    Proc Assoc Am Phys

    (1997)
  • H. Karlic et al.

    Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes

    J Mol Med

    (2003)
  • H.R. Brown et al.

    Correlation of simultaneous differential gene expression in the blood and heart with known mechanisms of adriamycin-induced cardiomyopathy in the rat

    Toxicol Pathol

    (2002)
  • M. Schoderbeck et al.

    Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes

    J Perinat Med

    (1995)
  • J. Bremer

    Carnitine—metabolism and functions

    Physiol Rev

    (1983)
  • L.L. Bieber

    Carnitine

    Annu Rev Biochem

    (1988)
  • S. Berardi et al.

    Characterization of a sodium-dependent transport system for butyrobetaine into rat liver plasma membrane vesicles

    Hepatology

    (1998)
  • F.M. Vaz et al.

    Carnitine biosynthesis in mammals

    Biochem J

    (2002)
  • J.D. McGarry et al.

    The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

    Eur J Biochem

    (1997)
  • A.E. Jeukendrup

    Regulation of fat metabolism in skeletal muscle

    Ann NY Acad Sci

    (2002)
  • Y.E. Claessens et al.

    Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with l-carnitine

    Crit Care Med

    (2003)
  • J.D. Sweeney et al.

    l-carnitine decreases glycolysis in liquid-stored platelets

    Transfusion

    (2000)
  • G. Van Hall

    Lactate as a fuel for mitochondrial respiration

    Acta Physiol Scand

    (2000)
  • G. Van Hall et al.

    Skeletal muscle substrate metabolism during exercisemethodological considerations

    Proc Nutr Soc

    (1999)
  • N.J. Faergeman et al.

    Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling

    Biochem J

    (1997)
  • C. Barnett et al.

    Effect of L-carnitine supplementation on muscle and blood carnitine content and lactate accumulation during high-intensity sprint cycling

    Int J Sport Nutr

    (1994)
  • R.G. Villani et al.

    l-carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women

    Int J Sport Nutr Exerc Metab

    (2000)
  • P. Walter et al.

    l-carnitine, a vitamin-like substance for functional food. Proceedings of the symposium on l-carnitine, April 28 to May 1, 2000, Zermatt, Switzerland

    Ann Nutr Metab

    (2000)
  • S. Obici et al.

    Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production

    Nat Med

    (2003)
  • Cited by (0)

    This study was supported by the Bürgermeisterfonds der Stadt Wien.

    View full text